AR094650A1 - CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATE - Google Patents

CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATE

Info

Publication number
AR094650A1
AR094650A1 ARP140100022A ARP140100022A AR094650A1 AR 094650 A1 AR094650 A1 AR 094650A1 AR P140100022 A ARP140100022 A AR P140100022A AR P140100022 A ARP140100022 A AR P140100022A AR 094650 A1 AR094650 A1 AR 094650A1
Authority
AR
Argentina
Prior art keywords
glatiramer acetate
product related
pharmacological
substance
drug
Prior art date
Application number
ARP140100022A
Other languages
Spanish (es)
Inventor
Schwartz Rivka
Bakshi Shlomo
Daniel Fowler Kevin
George Towfic Fadi
Michael Funt Jason
James Zeskind Benjamin
Artomov Maksym
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of AR094650A1 publication Critical patent/AR094650A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Proceso para caracterizar una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer que comprende los pasos de: a) obtener un lote de la una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer; b) inmunizar un mamífero con una cantidad predeterminada de una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer; c) preparar un cultivo de células del mamífero del paso b) a un tiempo predeterminado después de la inmunización; d) incubar las células del cultivo del paso c) con una cantidad predeterminada de la una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer del paso a); y e) determinar el nivel de expresión de al menos un gen descrito en la presente o determinar el nivel de actividad biológica de las células del paso c) como se describe en la presente, caracterizando de este modo la una sustancia farmacológica o producto farmacológico relacionado con acetato de glatiramer del paso a).Process for characterizing a pharmacological substance or drug product related to glatiramer acetate comprising the steps of: a) obtaining a batch of the one drug substance or drug product related to glatiramer acetate; b) immunize a mammal with a predetermined amount of a drug substance or drug product related to glatiramer acetate; c) preparing a culture of mammalian cells from step b) at a predetermined time after immunization; d) incubating the culture cells of step c) with a predetermined amount of the a pharmacological substance or glaciramer acetate related product of step a); and e) determine the level of expression of at least one gene described herein or determine the level of biological activity of the cells of step c) as described herein, thereby characterizing the pharmacological substance or pharmacological product related to Glatiramer acetate from step a).

ARP140100022A 2013-01-04 2014-01-03 CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATE AR094650A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361749228P 2013-01-04 2013-01-04

Publications (1)

Publication Number Publication Date
AR094650A1 true AR094650A1 (en) 2015-08-19

Family

ID=56117426

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100022A AR094650A1 (en) 2013-01-04 2014-01-03 CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATE

Country Status (1)

Country Link
AR (1) AR094650A1 (en)

Similar Documents

Publication Publication Date Title
PE20151980A1 (en) CHARACTERIZATION OF A GLATIRAMER ACETATE RELATED MEDICINAL PRODUCT
AR103161A1 (en) ANTIMIOSTATINE ANTIBODIES AND VARIANTS FC REGIONS AS WELL AS METHODS OF USE
BR112020003925A2 (en) Edible food products and bioreactor designs
CU20160159A7 (en) PROCESS OF REGULATED CELL CELLULAR OF EUCARIOT CELLS AND DERIVATIVE PRODUCTS AND METHOD OF GENERATION OF VEGETABLE CELL MATERIAL IN THE FORM OF A MULTI-PAPER CELLULAR PACK, NOT WOVEN AND STRUCTURED POROUS, PRIVATE OF THE ENVIRONMENT
AR090017A1 (en) FGFR1 AGONISTS AND THEIR METHODS OF USE
AR091098A1 (en) ANTIBODIES AND IMMUNOCATED TO Ly6E AND METHODS OF USE
AR096839A1 (en) IMPROVED PROCESS FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES
AR093398A1 (en) PROPAGATION OF YEAST AT A CONTROLLED pH
EP4300070A3 (en) Culture patch, culture method, method and apparatus for testing culture, and method and apparatus for testing medicine
MX366369B (en) Method for a cell-based drug screening assay and the use thereof.
AR094389A1 (en) USE OF iNOS INHIBITORS TO INCREASE THE VIVIC PERFORMANCE IN CROPS
BR112016028512A8 (en) method of culturing a mammalian cell and method of producing a recombinant protein
PE20141133A1 (en) APPARATUS AND PROCESS FOR THE PRODUCTION OF AN ENCAPSULATED CELL PRODUCT
BR112018012070A2 (en) method for the production of tissues / organs using blood cells
MX366112B (en) Cell culture media and methods of antibody production.
MX2016004616A (en) Muscle cell patches and uses therefor.
IL246525B (en) Pomegranate derived cell culture and methods for preparing and using the same
MX2022003399A (en) Cellular-based method for determining the potency of defibrotide.
BR112018000168A2 (en) A manufacturing method of a quality iPS cell
BR112015029081A2 (en) MYCELIOPHTHORA THERMOPHILA HOST CELL EXPRESSING A RECOMBINANT BETA-XYLOSIDASE ENZYME, RECOMBINANT BETA-XYLOSIDASE ENZYME EXPRESSED THROUGH THE SAME, COMPOSITION, USE OF HOST CELL, BETA-XYLOSIDASE ENZYME OR COMPOSITION AND METHODS OF PRODUCING FERMENTED SUGARS AND PRODUCTION OF BIO PRODUCTS OF BIOMASS
AR104050A1 (en) PRODUCTION PROCESS WITH CONTROLLED COPPER IONS
EP3067416A4 (en) Method for introducing exogenous mitochondria into mammalian cells
EP3270934A4 (en) Microcarriers, matrices and scaffolds for culturing mammalian cells and methods of manufacture
UY36197A (en) BIOLOGICAL CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT DERIVED FROM GLATIRAMER ACETATE BY HUMAN AND NON-HUMAN MAMMAL CELLS
AR094650A1 (en) CHARACTERIZATION OF A PHARMACOLOGICAL PRODUCT RELATED TO GLATIRAMER ACETATE

Legal Events

Date Code Title Description
FB Suspension of granting procedure